These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 35880031)
1. Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer. Li Y; Qiu Z; Wang Q; Li S; Zhang Q; Han J Biomed Res Int; 2022; 2022():3465391. PubMed ID: 35880031 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer. Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of an immune prognostic signature in colorectal cancer. Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer. Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319 [TBL] [Abstract][Full Text] [Related]
5. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
6. Construction of an immune gene expression meta signature to assess the prognostic risk of colorectal cancer patients. Orozco-Castaño C; Mejia-Garcia A; Zambrano Y; Combita AL; Parra-Medina R; Bonilla DA; González A; Odriozola A Adv Genet; 2024; 112():207-254. PubMed ID: 39396837 [TBL] [Abstract][Full Text] [Related]
7. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer. Cai Z; Zhou F Medicine (Baltimore); 2022 Nov; 101(46):e31127. PubMed ID: 36401385 [TBL] [Abstract][Full Text] [Related]
8. A five-immune-related genes-based prognostic signature for colorectal cancer. Zhu L; Wang H; Wang Z Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411 [TBL] [Abstract][Full Text] [Related]
9. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer. Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544 [TBL] [Abstract][Full Text] [Related]
10. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients. Shen KY; Chen BY; Gao WC Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507 [TBL] [Abstract][Full Text] [Related]
11. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients. Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357 [TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer. Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777 [TBL] [Abstract][Full Text] [Related]
13. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction. Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226 [TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients. Fan Q; Liu B J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531 [TBL] [Abstract][Full Text] [Related]
15. A novel prognostic signature of immune-related genes for patients with colorectal cancer. Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470 [TBL] [Abstract][Full Text] [Related]
16. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001 [TBL] [Abstract][Full Text] [Related]
17. Integrated analysis reveals a novel 5-fluorouracil resistance-based prognostic signature with promising implications for predicting the efficacy of chemotherapy and immunotherapy in patients with colorectal cancer. Hou Y; Zhang F; Zong J; Li T; Gan W; Lv S; Yan Z; Zeng Z; Yang L; Zhou M; Zhao W; Yang M Apoptosis; 2024 Aug; 29(7-8):1126-1144. PubMed ID: 38824480 [TBL] [Abstract][Full Text] [Related]
18. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients. Wang S; Cheng L; Jing F; Li G BMC Med Genomics; 2022 Aug; 15(1):177. PubMed ID: 35941638 [TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma. Liu J; Lu J; Li W Front Immunol; 2021; 12():738068. PubMed ID: 34630418 [TBL] [Abstract][Full Text] [Related]
20. A novel oxidative stress- and ferroptosis-related gene prognostic signature for distinguishing cold and hot tumors in colorectal cancer. Wang X; Xu Y; Dai L; Yu Z; Wang M; Chan S; Sun R; Han Q; Chen J; Zuo X; Wang Z; Hu X; Yang Y; Zhao H; Hu K; Zhang H; Chen W Front Immunol; 2022; 13():1043738. PubMed ID: 36389694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]